Literature DB >> 31087122

Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship.

Marian S Wettstein1,2, Clinsy Pazhepurackel1, Aline S Neumann1, Dixon T S Woon2, Jaime O Herrera-Caceres2, Marko Kozomara1, Cédric Poyet1, Tullio Sulser1, Girish S Kulkarni2, Thomas Hermanns3.   

Abstract

PURPOSE: To investigate the outcomes of comparative studies on photoselective vaporization of the prostate (PVP) as a function of risk of bias (RoB), conflicts of interest (COI), and industrial sponsorship (IS).
METHODS: We performed a systematic literature search for comparative studies on PVP [randomized controlled trials (RCTs) and non-randomized comparative studies (NRCSs)]. Study selection as well as comprehensive assessment of RoB, COIs, and IS were performed in duplicate. The identified studies were further rated by two independent board-certified urologists as either PVP-favourable or PVP-unfavourable. Descriptive statistics were performed among all identified studies and among the subgroups of studies rated as favourable and unfavourable, respectively.
RESULTS: Sixty-five studies qualified for inclusion (25 RTCs and 40 NRCSs) of which 56 (86%) were rated favourable and 9 (14%) unfavourable. A majority of all studies mentioned the absence/presence of potential COIs (78%). In contrast, a sponsorship statement was only found in 29% of the investigations. Studies rated favourable demonstrated a higher percentage of COIs (39% versus 22%). IS was exclusively found among favourable studies. Furthermore, a serious or critical RoB was more often found in favourably rated NRCSs.
CONCLUSIONS: COIs and IS seem to be associated with favourable study outcomes in comparative studies on PVP. The transparency of the whole research process from study conception to the dissemination of the results has to be further improved to prevent a harmful effect of COIs and IS on the internal validity of studies.

Entities:  

Keywords:  Bias; Conflict of interest; Financial disclosure; Laser therapy; Prostatic hyperplasia

Mesh:

Year:  2019        PMID: 31087122     DOI: 10.1007/s00345-019-02799-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014.

Authors:  Martin Schoenthaler; Arkadiusz Miernik; Konrad Wilhelm; Daniel Schlager; Dominik Stefan Schoeb; Fabian Adams; Philipp Dahm; Simon Hein
Journal:  BJU Int       Date:  2015-12-29       Impact factor: 5.588

3.  Industry support and correlation to study outcome for papers published in Spine.

Authors:  Rahul V Shah; Todd J Albert; Victoria Bruegel-Sanchez; Alexander R Vaccaro; Alan S Hilibrand; Jonathan N Grauer
Journal:  Spine (Phila Pa 1976)       Date:  2005-05-01       Impact factor: 3.468

4.  Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations.

Authors:  Kanu Okike; Mininder S Kocher; Charles T Mehlman; Mohit Bhandari
Journal:  J Bone Joint Surg Am       Date:  2007-03       Impact factor: 5.284

5.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

6.  The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.

Authors:  Safdar N Khan; Matthew J Mermer; Elizabeth Myers; Harvinder S Sandhu
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2008-12

Review 7.  Influences on the quality of published drug studies.

Authors:  L A Bero; D Rennie
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

8.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  Eur Urol       Date:  2013-11-11       Impact factor: 20.096

9.  Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal.

Authors:  P A Rochon; J H Gurwitz; C M Cheung; J A Hayes; T C Chalmers
Journal:  JAMA       Date:  1994-07-13       Impact factor: 56.272

10.  A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  J Urol       Date:  2014-09-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.